THE RETAIL BULLETIN - The home of retail news
Home Page
News Categories
Christmas Ads
Commentary
Department Stores
Electricals & Technology
Entertainment
Fashion
Food & Drink
General Merchandise
Grocery
Health & Beauty
Home & DIY
Interviews
Property
Retail News
Retail Solutions
Shopping Centres, High Streets & Retail Parks
Sports & Leisure
Retail Events
People in Retail Awards 2023
Retail Marketplace Strategy 2023
Omni Channel Futures 2023
Retail HR Central
Digital Transformation Strategy 2023
Customer Engagement Strategy 2023
Retail HR 2023
THE Retail Conference 2023
Upcoming Retail Events
Past Retail Events
Retail Insights
Retail Solutions
Advertise
About
Contact
Subscribe for free
Terms and Policies
Privacy Policy
THG says Dermologica is not restricting stock over discounting concerns

Matthew Moulding’s online beauty, wellness and software giant THG has denied suppliers are restricting stock over concerns about ‘aggressive discounting’. The Manchester-headquartered group has issued a… View Article

HEALTH & BEAUTY

THG says Dermologica is not restricting stock over discounting concerns

Matthew Moulding’s online beauty, wellness and software giant THG has denied suppliers are restricting stock over concerns about ‘aggressive discounting’.

The Manchester-headquartered group has issued a statement to the London Stock Exchange after reports that Dermologica, which is owned by Unilever, is one of a number of brands that have reduced supplies to protect their pricing.

The response from THG comes after the firm’s share price tumbled to its lowest level ever yesterday following reports it was locked in a dispute with Unilever subsidiary Dermalogica  on the grounds it was discounting products too heavily in order to hit sales targets.

THG said today that reports of the dispute were “media speculation” and there was “no notifiable reason” for the firm’s plummeting share price yesterday.

“Dermalogica has not placed and is not looking to place any restrictions on its trading relationship with THG Beauty, including with regard to the supply of stock,” THG said.

“The Dermalogica and THG Beauty trading relationship is over 10 years in length and whilst it remains very positive the overall revenues generated are de minimis to the Group, at c.0.1% of FY 2021 sales.”

Bosses at THG said they are “not aware” of any key suppliers to THG’s beauty division that have or intend to restrict supply to its beauty division.

The rebuttal comes amid reports of growing unease from suppliers over the firm’s pricing strategy. An industry source at one supplier told The Telegraph: “They (Dermalogica) are not the only ones. Working with THG is not easy because of the high profit margins they need, but when they tear down your brand too it’s not worth it.”

Boss Matt Moulding has overseen a disastrous slide in the firm’s share price since it floated last year, with THG currently trading at 85 per cent discount to its floatation price.

Private equity firms are said to now be circling the business and readying a bid, while bankers are Barclays and Jefferies are advising THG to fend off a hostile takeover approach.

Moulding’s rebuttal of the rumours settled some investor concerns, with the firm’s share price jumping around 5 per cent in early trading.

Email this article to a friend

You need to be logged in to use this feature.

Please log in here

Subscribe For Retail News